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1. Introduction 
The inventory of atypical1 bacteria that may be found in the airways of cystic fibrosis (CF) 
patients besides well-known typical CF pathogens like Staphylococcus aureus, Haemophilus 
influenzae, Pseudomonas aeruginosa and Burkholderia cepacia complex has greatly evolved over 
the past decades. Progressively, species initially considered as atypical in the CF airways, 
mainly gram-negative bacilli including Stenotrophomonas maltophilia, Achromobacter 
xylosoxidans and non-tuberculous mycobacteria have received more and more attention. 
They are now considered as usual CF-associated bacteria although their role in the disease 
progression is not fully elucidated (Beringer et al., 2000; Foweraker, 2009; Hauser et al., 2011). 
At the same time, other species occasionally identified from the respiratory secretions of CF 
patients were in turn regarded as atypical species in CF (for a recent review, see Hauser et 
al., 2011). This resulted from both the increasing number of metagenomic studies conducted 
on CF airways microbiota and a more systematic use of 16S ribosomal RNA (rRNA) gene 
sequencing to identify bacteria cultured from CF respiratory tract (CFRT) samples (CFRTS).  
Recent findings of “new” atypical bacterial species in CF airways by both cultivation-based 
and cultivation-independent studies gave novel insights in microbiology of the CFRT. 
However, pathogenesis and clinical significance of these bacteria remain unclear, i.e. 
adaptation to the CF airways niche, positive or negative interaction between organisms, 
impact on the respiratory status of the patients. Similarly, antimicrobial susceptibility 
pattern is more often not investigated for atypical bacteria.  
In this chapter, we propose a review of both published studies and personal findings about 
atypical bacterial species found in CF airways by both cultivation-based and cultivation-
independent studies. Personal data came from our expertise of 16S rRNA gene-based 
identification of atypical bacteria cultured from CFRTS in patients attending the CF center of 
                                                 
1The term "atypical" will be used herein to design bacterial species rarely reported in the literature 
dealing with the microbiology of respiratory tract in CF patients. 
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the Montpellier University Hospital2. Most of these atypical bacteria are either environmental 
bacteria or belong to the human respiratory tract microbiota. In this context, examples will be 
mainly taken from a selected panel of bacteria in our area of expertise, including human 
anaerobic bacteria and environmental alphaproteobacteria: Agrobacterium, acetic acid bacteria, 
Ochrobactrum and Inquilinus. 
2. CF airways, a niche for environmental opportunistic pathogens 
CF airways represent a particular niche in which recent cultivation-based and cultivation-
independent studies revealed several atypical microbes, which were recently reviewed by 
Hauser et al. (Hauser et al., 2011). Most of these bacteria are from environmental origin and act 
as opportunistic pathogens. Some isolates corresponded to unknown taxa when cultivated 
from CFRTS and supported the description of novel species such as Inquilinus limosus (Coenye 
et al., 2002). Other isolates corresponded to species isolated for the first time in man such as the 
acetic acid bacteria of the genus Gluconobacter previously recovered from environmental and 
food sources only (Alauzet et al., 2010). We previously reported eight other species detected in 
CF airways samples but so far described in food or environmental samples only: Acetobacter 
fabarum, Advenella kashmirensis, Aquamicrobium lusatiense, Chryseobacterium bovis, Phyllobacterium 
myrsinacearum, Pseudomonas brenneri, Shinella yambaruensis and Sphingomonas pseudosanguinis 
(Jumas-Bilak et al., 2011). This diversity suggested that the microbiota of the CF airways niche 
was far to be fully described. Finally, other isolates were identified as environmental bacteria 
also known to cause opportunistic infections in immunocompromised patients, for example 
members of the genera Agrobacterium or Ochrobactrum (Menuet et al., 2008).  
2.1 Atypical bacteria identified by molecular means in our center 
The following paragraphs and Table 1 present a summary about the atypical bacterial 
species cultivated from the respiratory tract of CF patients and identified by 16S rRNA gene 
sequencing in our center.  
Methods performed for bacterial DNA extraction, 16S rRNA gene amplification and 
sequencing and sequence analysis were described elsewhere; particularly a threshold of 98.7% 
was considered for species identification (Stackebrandt & Ebers, 2006; Teyssier et al., 2003). A 
total of 23 atypical taxa were identified in 30 CFRTS from 25 patients. Three patients were 
colonized by 2 to 3 of these atypical species recovered either in a sample or in two distantly 
sampled specimens. Fourteen species had never been reported in man before being identified 
in CF patients, 6 were previously isolated in human clinical samples but were not previously 
reported in CF patients and 3 species were only isolated in CF patients. Among the taxa not 
previously isolated in man, four have been found in cultivation-independent studies of human 
biological samples, Cupriavidus metallidurans in skin microbiota (Grice et al., 2009), Cupriavidus 
respiraculi in small intestine microbiota (Franck et al., 2007), P. myrsinacearum in vaginal 
microbiota (Hyman et al., 2005) and S. pseudosanguinis in diabetic wound microbiota (Grice et 
al., 2010). Species subjected to detailed paragraphs were not included in Table 1. They were 
chosen to complete available recent reviews and/or to give information from personal data.  
                                                 
2Caring for more than 200 children and adults each year - 95 adults and 110 children in 2009, the CF 
center of the Montpellier University Hospital is a large regional French CF center. 
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Advenella kashmirensis (1) Temperate orchard soil NPR NPR Ghosh et al., 2005 
Aquamicrobium lusatiense
(2) 
Activated sludge  NPR NPR Fritsche et al., 1999 
Chromobacterium 
aquaticum (9) 
Spring-water NPR NPR Young et al., 2008 
Chryseobacterium bovis (3) Cow’s milk NPR NPR 
Hantsis-Zacharov et al., 
2008 
Comamonas koreensis (4) Forest sediment, wetland NPR NPR Chang et al., 2002 
Phyllobacterium 
myrsinacearum (5) 
Leaf nodules of tropical 
plants 
NPR NPR Mergaert et al., 2002 
Pseudomonas brenneri (6) Natural mineral waters NPR NPR Baïda et al., 2001 
Pseudomonas nitroreducens
(10) 
Rhizospheric soil NPR NPR Korade et al., 2009 
Shinella yambaruensis (7) Soil NPR NPR Matsui et al., 2009 
Sphingomonas 
pseudosanguinis (8) 
Water reservoir of air 
humidifier 
NPR NPR Kämpfer et al., 2007a 
Chryseobacterium 
indologenes (3) 
Water, soil, hospital 
environment 





sludge, rhizoplane  
Catheter NPR Preiswerk et al., 2011 
Microbacterium sp.a (3) 
Rhizosphere, mosquito, 
medical wastes 
Various NPR Gneiding et al., 2008 
Nocardia cyriacigeorgicab 
(12-15) 
Soil, animals (bovin, cat, 
dog) 
Various NPR Schlaberg et al., 2008 
Tsukamurella sp.c (4) Activated sludge 
Blood, RTS, brain, 
cornea 
NPR Sheng et al., 2009 
Wautersiella falsenii (11) Poultry Various NPR Kämpfer et al., 2006 
Cupriavidus metallidurans 
(19) 
Industrial biotopes  NPR 2 isolates Coenye et al., 2005 
Cupriavidus respiraculi
(20, 21) 
NPR NPR 23 isolates Coenye et al., 2005 
Pandoraea apista (22) NPR NPR 22 isolates Atkinson et al., 2006 
Pandoraea pulmonicola (23) NPR NPR 2 isolates Coenye et al., 2000 
Bordetella petrii  (24) 
Polluted soil, river 
sediment, marine 
sponges, grass root 
Bone, RTS 5 isolates Spilker et al., 2008 
Brevundimonas diminuta (25)
Water, marine soil, 
petroleum oil, food 
Various 1 isolate Menuet et al., 2008 
Nocardia farcinicab (22) Activated sludge, animals Various 3 isolates Bittar et al., 2010 
a 16S rRNA gene sequencing did not allow discrimination between Microbacterium oxydans and 
Microbacterium paraoxydans. 
b Species identification was achieved by the Observatoire National des Nocardioses laboratory, Lyon, 
France, due to lack of discrimination between several nocardial species using 16S rRNA gene 
sequencing. 
c No discrimination between Tsukamurella tyrosinosolvens and Tsukamurella pulmonis. 
NPR, not previously reported; RTS, respiratory tract sample 
Patients’ designation in bold type indicated patients with other samples positive for atypical species 
listed either in Table 1 or in Table 3. 
Table 1. Atypical bacterial species identified by 16S rDNA sequencing in CFRTS from 
patients attending the center of the University Hospital of Montpellier and general data on 
isolation in non-human specimens, in non-CF and CF patients. 
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I. limosus is a gram-negative bacilli that grew slowly with non-pigmented and extremely 
mucoid colonies (Figures 1C and 1E) (Coenye et al., 2002). This alphaproteobacteria belongs 
to the order Rhodospirillales and to the family Rhodospirillaceae that groups environmental 
non-sulfur purple bacteria (Table 2). Members of this family were never isolated in man 
except for I. limosus that appeared human-associated. Since its characterization from CFRTS 
in 2002, I. limosus was regularly reported, mainly from CFRT (Bittar et al., 2008a; Chiron et 
al., 2005; Coenye et al., 2002). Most patients with Inquilinus were chronically colonized by P. 
aeruginosa and Inquilinus chronic colonization appeared usual in CF patients (Chiron et al., 
2005; Hayes et al., 2009; Schmoldt et al., 2006). Typing Inquilinus strains by random amplified 
polymorphic DNA (RAPD) and pulsed-field gel electrophoresis (PFGE) revealed no cross-
transmission within centers and a diversity of contamination sources (Chiron et al., 2005; 
Schmoldt et al., 2006).  
In our center, a 21-year-old patient is chronically colonized by Inquilinus sp. since the age 
of 12 years (Chiron et al., 2005). The patient has chronic colonization by a methicillin-
susceptible S. aureus and was transiently colonized by P. aeruginosa (3 P. aeruginosa strains 
isolated since Inquilinus recovery and no P. aeruginosa isolated since 4 years). Inquilinus sp. 
bacterial load ranged from 104 to up to 108 CFU/ml depending on the sample, 
representing the dominant or one of the major species in the sputum samples. Despite 
environmental investigation, the source for infection remained unknown for this patient. 
Environmental sources for Inquilinus contamination are highly suspected but they were 
never traced. More generally, no environmental niche for I. limosus is detected when 
screening sequences deposited for environmental clones in the GenBank database 
(http://www.ncbi.nlm.nih.gov/genbank/).  
2.3 Acetic acid bacteria  
Members of the genus Acetobacter, Gluconobacter and Asaia were recently isolated from the 
respiratory tract of CF patients. These gram-negative bacilli belong to the family 
Acetobacteraceae, the second family forming the order Rhodospirillales in the 
alphaproteobacteria together with Rhodospirillaceae, the family of Inquilinus (Table 2). 
Acetobacter, Gluconobacter and Asaia are Acetic Acid Bacteria (AAB) characterized by their 
ability to oxidize alcohols or sugars, leading to the production of acetic acid. AAB are 
commonly found in soil or are associated with plants. They have been used in industrial 
food processing throughout human history, especially to convert wine to vinegar and to 
produce tropical fermented products (Yamada & Yukphan, 2008). The first report of human 
infection involving AAB dates from 2004, i.e. a case of peritonitis associated with Asaia 
bogorensis (Snyder et al., 2004). Since then, AAB have increasingly been reported as 
organisms potentially infecting humans and were firstly recognized in a CF patient in 2008 
(Alauzet et al., 2010; Bittar et al., 2008a).  
We reported four additional AAB isolates in 3 CF patients as follows: (i) successive isolation 
of an Asaia sp. and of two unrelated Gluconobacter sp. in a 2-year-old CF patient, (ii) a 
Gluconobacter sp. isolate unrelated to the strains from previous patient and recovered in a 3-
year-old CF patient followed at the same CF center, (iii) an A. fabarum isolate in a 19.5-year-
old CF patient (Alauzet et al., 2010; Jumas-Bilak et al., 2011). In these cases, AAB were 
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recovered at low bacterial load in the sputum samples (≤8 x 103 CFU/ml). AAB strains 
usually grew in 24 to 72 h at 30°C on various agar media selective for gram-negative bacteria 
except MacConkey agar whereas culture on the same media at 37°C yielded very tiny 
colonies (Figure 1D) (Alauzet et al., 2010; Bittar et al., 2008a). More generally, reports of A. 
fabarum, an AAB species recently characterized from fermented Ghanaian cocoa beans, and 
of Gluconobacter sp. increased the list of AAB, recently recognized as emerging opportunistic 
human pathogens, recovered from human samples (Alauzet et al., 2010; Cleenwerck et al., 
2008). 
2.4 Agrobacterium 
Members of the order Rhizobiales and of the family Rhizobiaceae, Agrobacterium spp. are gram-
negative, non-fastidious, non-fermentative short rods that form mucoid or non-mucoid 
colonies on agar media (Dunne et al., 1993). Agrobacterium are recovered from soil 
rhizosphere and are well-known plant-associated bacteria that may be phytopathogens. 
Modified strains of Agrobacterium tumefaciens are widely used in plant engineering. In the 
past two decades, Agrobacterium radiobacter has been recognized as an opportunistic human 
pathogen responsible for nosocomial infections, mainly bacteremia, peritonitis, and urinary 
tract infections despite virulence considered to be low (Chen et al., 2008; Edmond et al., 
1993). In 2002, four A. radiobacter strains have been isolated from the respiratory tract of CF 
patients and it has been suggested that A. radiobacter may have the potential to spread from 
patient to patient (Coenye et al., 2002).  
In 2010, we reported 19 additional isolates of Agrobacterium sp. from 17 CF patients; strains 
were analyzed by multilocus sequence typing (MLST) showing 11 different Sequence Types 
(STs), 17 of the 19 strains belonging to the genovar A7, a genovar that contained only clinical 
strains and probably adapted to human beings. Diversity in a single ST was demonstrated 
by PFGE showing that cross-contamination between patients did not occur in our center 
(Aujoulat et al., 2010). A. radiobacter was mainly recognized during transient colonization, no 
other isolate being recovered in the follow-up of most patients (19 patients out of the 22 
currently colonized in our center, 86.4%). Patients’ age at A. radiobacter isolation ranged from 
6 months to 29 years (mean age, 9 years). Successive episodes of colonization occurred in 3 
patients, from 2 months to 1.5 year apart. One of these cases was investigated by typing 
methods showing 2 unrelated isolates recovered 1.5 year apart. In three patients, two A. 
radiobacter isolates with different cultural characteristics were observed in a sample. One of 
these cases was further investigated showing the patient to be colonized by two genetically 
different and genomically unrelated strains. Bacterial load in samples was relatively low for 
most cases comprised between 102 and 103 CFU/ml except for three samples where the load 
was higher (from 104 to 2 x 106 CFU/ml) but A. radiobacter was not the dominant species. 
These samples were taken during scheduled consultation for two patients and during 
exacerbation attributed to H. influenzae for the third patient. Bacterial species mainly co-
isolated are the usual pathogens S. aureus (9 patients) and H. influenzae (5 patients) while co-
isolation of P. aeruginosa was noted in one patient only. Of note, A. radiobacter is usually 
recovered in highly diversified polymicrobial cultures associated with other rarely isolated 
organisms like Acinetobacter spp., B. diminuta, Comamonas acidovorans, C. indologenes, C. 
respiraculi, D. tsuruhatensis, Enterobacteriaceae (9 different species), Ochrobactrum anthropi, 
Tsukamurella sp. or Roseomonas sp. (16 out of 22 patients). 
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Another member of the order Rhizobiales in alphaproteobacteria, the genus Ochrobactrum 
groups bacteria increasingly reported in CF (Menuet et al., 2008; Yagüe-Muñoz et al., 
2010). First considered as an emerging pathogen by Menuet et al., O. anthropi was 
responsible for a bacteremia in CF. Ochrobactrum spp. are gram-negative non-fermentative 
oxidase-positive short rods recovered from a wide variety of environmental sources 
(water, soil, rhizosphere) as well as from plants, animals and human. Five species, O. 
anthropi, O. intermedium, O. pseudintermedium, O. haematophilum and O. pseudogrignonense 
were recovered from human samples; the first two species being increasingly reported as 
opportunistic pathogens mainly during nosocomial infections, particularly bacteremia 
and endocarditis (Kämpfer et al., 2007b; Teyssier et al. 2005, 2007). Ochrobactrum spp. do 
not present exigent cultural requirements and colony morphology depends on the species 
(Teyssier & Jumas-Bilak, 2011). 
In our center, 14 patients are colonized by Ochrobactrum spp. strains (mean age, 3 years 
[10 months-18 years]) and 35 isolates were recovered (one to 10 isolates per patient). 
Serial isolates were isolated in seven patients. O. anthropi was the major species 
recovered in CF patients, all the isolates except three being identified as O. anthropi. 
Moreover, O. intermedium (n=1) and O. pseudogrignonense (n=2) were isolated from 
patients also colonized by O. anthropi. The relative importance of species observed in CF 
did not reflect the distribution of species in the general population where O. intermedium 
was more frequently represented (Teyssier et al., 2003). In a collection of 66 Ochrobactrum 
spp. from the non-CF population attending the University Hospital of Montpellier, 
species identified by molecular means were distributed as follows: O. anthropi (n=37, 
56.1%), O. intermedium (n=25, 37.9%), O. pseudogrignonense (n=1, 1.5%), and O. 
pseudintermedium (n=3, 4.5%) (unpublished data). Two strains of O. pseudogrignonense 
recovered from human clinical samples (blood and ear) supported the description of the 
species in 2007, then this recently described species was recovered from CFRTS, two 
patients attending our center being colonized by unrelated O. pseudogrignonense strains. 
Main associated bacteria were S. maltophilia (8 patients), Enterobacteriaceae (7 patients), 
and S. aureus and H. influenzae (6 patients each). Concomitant isolation of P. aeruginosa 
was observed for 6 samples from 4 patients while co-isolation of atypical species like A. 
radiobacter, Acinetobacter spp., Alcaligenes spp., A. kashmirensis, C. acidovorans, C. 
indologenes, D. tsuruhatensis and S. paucimobilis was frequently observed. Bacterial load 
was comprised between 102 and 4 x 104 CFU of Ochrobactrum spp./ml and in most 
samples Ochrobactrum spp. were not the dominant species. Molecular typing based on 
PFGE and MLST revealed a high level of diversity among isolates showing that no 
epidemic strains spread occurred in our center (Romano et al., 2009). The same typing 
methods showed that serial isolates recovered from a patient could correspond to 
successive colonization by unrelated strains. Such successive episodes of colonization 
were observed in 5 patients. By contrast, chronic colonization was noted over a 10-month 
period (4 serial isolates) for one patient with intercurrent isolation of unrelated O. 
anthropi strains and for a 3-year period in a second patient (2 isolates). Complex route of 
colonization by Ochrobactrum spp. in CF is revealed here and warrants further 
investigation to search for the diversity of sources. 
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2.6 How unusual are atypical CF-associated bacteria? 
2.6.1 Incidence of atypical species in CF  
When looking at the isolation frequency of the atypical bacteria described by Hauser et al. in 
our CF center, we found that most of the taxa cited were recovered from sputum samples of 
the patients thereby underlining that these species were not exceptionally isolated from 
CFRTS (Hauser et al., 2011).  
Strains whose identification was confirmed by 16S rRNA gene sequencing were listed in 
Table 1. Regarding other taxa detailed herein, AAB have been recovered from the 
respiratory tract of about 1% of the patients attending our CF center and are still to be 
considered as an unusual isolation in CF. Agrobacterium and O. anthropi isolates were 
found in about 10% and 7% of the patients, respectively and should not be considered 
anymore as unusual species in CFRT. Other species of Ochrobactrum are still to be 
considered as very unusually isolated in CF. A unique patient was chronically colonized 
by Inquilinus sp. in our CF center (0.5% of the patients) while higher incidence was 
reported in other CF centers. Notably, a higher incidence is reported in a neighbor region 
in South of France because Inquilinus was reported in 2.8% out of 145 CF patients, 
incidence varying according to age from 1.2% in children to 4.9% in adult patients (Bittar 
et al., 2008a). Inquilinus sp. was not found in the respiratory tract of non-CF patients (Bittar 
et al., 2008a). Interestingly, we observed that patients colonized by one of the previous 
taxa are often simultaneously or successively colonized by other of these species. For 
example, among the 22 patients with at least one isolate of Agrobacterium sp., 9 had at least 
one episode of colonization by another environmental alphaproteobacteria. The two 
patients with AAB were also colonized by A. radiobacter alone or associated with O. 
anthropi colonization. Other species or genera cited by Hauser et al. that were isolated in 
our center but not detailed here are Acinetobacter spp., Chryseobacterium spp. and members 
of the family Enterobacteriaceae. 
2.6.2 Atypical or underestimated species? 
Modification in cultivation and identification methods applied for CFRTS processing 
may explain an increasing rate of recovery of some species during CF. For example, AAB 
are increasingly recognized as emerging human opportunistic pathogens and their 
frequency may probably be underestimated because of their growth characteristics, 
particularly their faint growth at 37°C, a default temperature setting in routine medical 
microbiology, and because of the difficulty with identifying these microorganisms. For 
instance, the recovery of AAB in CF was related to the use of Burkholderia cepacia complex 
selective agar that is incubated for a prolonged incubation time (5 days) at 30°C. 
Therefore, the recovery of Asaia and Gluconobacter is enhanced because they resisted to 
antibiotics included in the medium and they grew in such cultivation conditions while 
no growth is observed on MacConkey agar plates incubated for 3 days at 30°C or 37°C 
(Alauzet et al., 2010) (Figure 1D).  
Growth of atypical bacteria on different media and at different incubation temperatures is 
shown in Figure 1. 
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Fig. 1. Growth of O. anthropi (A), A. radiobacter (B) and Inquilinus sp. (C) on MacConkey agar 
plates (bioMérieux) incubated at 37°C (left) or 30°C (middle) and on the Burkholderia cepacia-
selective medium Cepacia agar (AES) incubated at 30°C (right); growth of Gluconobacter sp. 
on B. cepacia-selective medium Cepacia agar (D), and growth of Inquilinus sp. on Mueller-
Hinton agar (bioMérieux) (E) (incubation time was 3 days in all cases). 
In addition to limitation related to cultivation conditions, recovery of atypical species could 
also be impaired by the routine practice of CFRT sampling. Indeed, the unique sample 
usually submitted to bacteriological analysis was shown to be insufficient for recognition of 
all bacteria that may colonize the patient, including CF pathogens (Rogers et al., 2010).  
Regarding identification, molecular-based methods revealed up to 25% of isolates without 
correct phenotypic identification (Bittar et al., 2008b). A. radiobacter strains are accurately 
identified with API 20NE strip or VITEK2 GN card (bioMérieux) but A. radiobacter is named 
Rhizobium radiobacter in API and VITEK2 databases due to confusing taxonomy in these 
genera (Aujoulat et al., 2010; Otto-Karg et al., 2009; Teyssier et al., 2009). Identification could 
be more difficult for other taxa. O. anthropi is the sole species of the genus included in API 
and VITEK2 databases. Both systems permit genus-level identification and sequencing of 
either 16S rRNA gene or another housekeeping gene should be performed for species 
identification. Although Inquilinus sp. showed several notable characteristics that will be 
discussed below, i.e. mucoid phenotype, characteristic multiresistant pattern to antibiotics 
and ability to persist in the CF airways, its identification remains difficult. This emerging 
pathogen was either not detected or misclassified by laboratories (Bittar et al., 2008b; Hogard 
et al., 2009). Since 2011, a second species has been described in the genus, Inquilinus 
ginsengisoli, isolated from soil (Jung et al., 2011). This species could be differentiated from I. 
limosus by a careful 16S rRNA gene analysis. Similarly, both genera of AAB recovered in CF 
patients, i.e. Asaia and Gluconobacter required molecular methods for their identification. 
However, some closely related species belonging to these genera might remain unidentified 
despite sequencing housekeeping genes in addition to 16S rRNA gene (Alauzet et al., 2010).  
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Recently, matrix-assisted laser desorption ionization–time of flight mass spectrometry 
(MALDI-TOF-MS) was used for identification of non-fermentative gram-negative bacilli 
isolated from CF patients (Degand et al., 2008). A few atypical species covered by this 
chapter were included, i.e. 1 B. hinzii, 1 I. limosus, 1 C. respiraculi. The three isolates were 
correctly identified by the system. Another study evaluating the system for identification of 
environmental members of the family Rhizobiaceae including Agrobacterium (= Rhizobium) 
radiobacter showed comparable performances to housekeeping gene sequence analysis 
suggesting that this species might be correctly identified by the system if included in the 
“CF” database (Ferreira et al., 2011). Additional studies on a larger panel of isolates are 
needed to precisely evaluate the performance of the system for identifying all the diversity 
of atypical bacteria that may be encountered in CF samples.  
2.7 Taxonomic diversity of atypical bacteria in CF 
Atypical taxa isolated from CFRTS in our center and identified by 16S rRNA gene 
sequencing are distributed among 3 phyla, the phylum Proteobacteria being the most 
represented. The Table 2 gives the taxonomic repartition of the atypical taxa in the 3 major 
phyla. In the Proteobacteria, gram-negative bacilli of the class Alphaproteobacteria account for 
the majority of atypical taxa identified (Table 2). This may suggest that patients are more 
frequently in contact with the environmental niches of these species and/or that these taxa 
have an increased potential to colonize the CFRT. 
 
 
Table 2. Taxonomic lineages for atypical bacteria identified from CFRTS in our center using 
16S rRNA gene sequencing. 
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2.8 Unknown cultivated bacterial taxa in CF 
Diversity of the cultivable part of the CFRT microbiota remains underestimated. In the past 
decade, 12 novel species were characterized based on isolates recovered in CFRTS, i.e. 7 
Burkholderia species, 3 Ralstonia species (of which 2 are yet reclassified in the genus 
Cupriavidus), Advenella incenata and I. limosus (PubMed search on August the 1st, 2011 with 
key words “sp. nov.” and “cystic fibrosis”). In our center, identification based on 16S rDNA 
revealed 5 potential novel taxa cultivated from CFRTS (Table 3). Of note, 2 patients had 
other samples positive for atypical species listed in Table 1. Altogether these data illustrate 






16S rDNA sequence similarity 
with the closest known species 
(%, name of the species) 
Taxonomic 
interpretation* 
29 dec. 2009, 
2320 
26 96%, Corynebacterium durum 
Novel species in the genus 
Corynebacterium 
15 jun. 2007, 
5197 
19 96.5%, Cupriavidus metallidurans 
Novel species in the genus 
Cupriavidus 
21 jul. 2009, 
2477 
27 97.6%, Roseomonas cervicalis 
Probable novel species in 
the genus Roseomonas 
20 nov. 2009, 
5248 
28 98.2%, Cupriavidus respiraculi 
Probable novel species in 
the genus Cupriavidus 
15 apr. 2005, 
5138 
6 98.5%, Cupriavidus respiraculi 
Probable novel species in 
the genus Cupriavidus 
* Isolates showing less than 97% of sequence similarity with the closest known species were considered 
as novel taxa (Stackebrandt & Goebel, 1994); isolates showing between 97% and 98.7% of sequence 
similarity with the closest known species were considered as probable novel taxa (Stackebrandt & 
Ebers, 2006). Bold type indicated patients with other samples positive for atypical species as listed in 
Table 1. 
Table 3. Unknown taxa in the CFRTS from patients attending the CF center of the University 
Hospital of Montpellier. 
3. Atypical pathologic communities in CF 
3.1 Microbial diversity in CFRT assessed by cultivation-independent studies 
Over the last decade, our knowledge of the bacterial diversity in CFRT microbiota has 
evolved due to cultivation-independent methods. Terminal Restriction Fragment Length 
Polymorphism Profiling, Temporal Temperature Gradient gel Electrophoresis or sequencing 
were employed to characterize 16S ribosomal DNA in CFRT community and revealed both 
a higher biodiversity than previously presumed and several atypical organisms (Bittar et al., 
2008b; Guss et al., 2011; Kolak et al., 2003; Rogers et al., 2004).  
Comparison between cultivation-based methods and cultivation independent methods 
revealed the overlooked part of bacteria present in CFRTS including species recovered from 
the oral microbiota during health and diseases, atypical species of unknown pathogenicity 
and well-known bacterial species pathogenic for CF patients (Bittar et al., 2008b; Rogers et 
al., 2009; van Belkum et al., 2000). For example, Bittar et al., studying 25 CF sputum samples 
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showed that 53 species were found using the PCR-cloning-sequencing approach while only 
13 were cultivated (Bittar et al., 2008b). Sixteen species only found by the molecular method 
corresponded to anaerobes not covered by the cultivation conditions used in the study. 
Nevertheless, several aerobic and anaerobic species detected by the genomic method 
corresponded to species unusually or firstly detected in CF (Bittar et al., 2008b).  
Additional unexpected bacteria were described in other cultivation-independent studies. 
For example, Harris et al. reported in a 14-year-old CF patient the first occurrence in man of 
sequences corresponding to the alphaproteobacteria Chelatococcus asaccharovorans (Harris et 
al., 2007). These sequences represented 5% of the total sequences found in the corresponding 
specimen. Some of the other unexpected bacteria overlooked by cultivation-based methods 
and revealed by cultivation-independent methods may be clinically relevant in CF. Indeed, 
CF candidate pathogens were identified by Harris et al. comparing microbiota from CF and 
non-CF patients as follows: Prevotella denticola, Lysobacter sp., and Rickettsiales sp. (Harris et 
al., 2007). Interestingly, members of the genus Lysobacter are gram-negative bacilli showing 
similar environmental lifestyle as Agrobacterium and Ochrobactrum, i.e. isolated from soil, 
rhizosphere and plant-associated samples. Lysobacter spp. were also found as dominant 
species on the human tongue dorsum and recovered from the surface of prosthetic hip joints 
(Dempsey et al., 2007; Riggio et al., 2008). Unless additional arguments are given, Lysobacter 
sp. should be considered with caution as a CF potential pathogen. Finally, cultivation-
independent studies revealed the occurrence of several unknown taxa in the CFRTS like 
novel members of the order Rickettsiales and of the family Coxiellaceae (the latter representing 
11% of the sequences found in association with those of Chelatococcus asaccharovorans) 
(Harris et al., 2007). Regarding bacterial taxa developed in this chapter, i.e. Inquilinus, acetic 
acid bacteria, Agrobacterium and Ochrobactrum, sequences of Inquilinus sp. were recovered in 
some cultivation-independent studies while the other taxa were not found (Bittar et al., 
2008b). In addition to patients’ sampling methods, these taxa may be overlooked in 
molecular-based approaches due to their minority in the CFRT microbiota, a hypothesis 
congruent with the low bacterial load observed in culture for these bacteria. 
3.2 Dysbiosis in the CF polymicrobial disease and example of anaerobes  
Comparison of microbiota diversity in CF patients and in control groups, as well as cultivation-
independent studies suggested that CF should be considered as a polymicrobial disease 
(Klepac-Ceraj et al., 2010; Sibley et al., 2006). A major recent finding revealed that lung function 
is significantly and positively correlated with the bacterial species richness of the global 
microbiota (van der Gast et al., 2011). Considering the inter-individual variations in the 
microbiota composition, van der Gast et al. studying microbiota composition of sputum samples 
from 14 adult CF patients further showed that both core and satellite taxa are significantly 
correlated with lung function (van der Gast et al., 2011). Moreover, any disequilibrium in the 
consortium of microorganisms found in the CFRT may have clinical consequences on the 
clinical status as previously observed in other dysbiosis-associated diseases like bacterial 
vaginosis (Oakley et al., 2008). Although the total number of bacterial species observed in a 
population of CF patients was shown significantly more diverse than that observed in a control 
group including bronchiectasis patients (Bittar et al., 2008b), at the individual level, libraries of 
lower complexity were observed in CF compared to a control group (Harris et al., 2007). Such a 
low diversity observed in CF patients may reflect the enrichment of a pathogenic species 
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and/or the consequence of dysbiosis and so possibly signify bacterial involvement in disease 
(Harris et al., 2007). For example, among the 28 CF patients included in the study, more than the 
half (53.6%) had less than 5 organisms detected and one of these microorganisms dominated the 
poorly diversified microbiota (from 63 to 98% of the sequences). For 8 patients, all sequences 
corresponded to a unique bacterial taxon (S. aureus, Lysobacter sp., S. maltophilia, P. aeruginosa 
and Mycobacterium abscessus). Atypical bacteria proposed as CF candidate pathogens and cited 
above, i.e. P. denticola, Lysobacter sp., and Rickettsiales sp. were all encountered in dysbiotic 
environment. Indeed, these sequences were each recovered in a CF patient as a major or as the 
unique sequence among sequences of the patient’s microbiota, representing 56%, 100% and 36% 
of the total sequences, respectively (Harris et al., 2007). Based on the example of P. denticola, we 
will discuss further on the role of anaerobes, particularly those belonging to the genus Prevotella, 
in the dysbiosis that may occur in CF (for a review on anaerobic bacteria infection in cystic 
fibrosis airway disease, see Lambiase et al., 2010).  
In both cultivation-based and cultivation-independent studies, particular attention was 
recently paid to anaerobic microflora, which had received little attention before (Bittar et al., 
2008b; Harris et al., 2007; Tunney et al., 2008). Indeed, anaerobic cultures are not performed 
in the routine practice of sputum samples and thus anaerobic bacteria are totally ignored 
except when specifically studied (Jewes & Spencer, 1990). Tunney et al. assessing anaerobic 
bacteria in CF children by means of culture of bronchoalveolar lavage fluid samples 
demonstrated that anaerobic bacteria are: (i) frequently present in the airway specimens, (ii) 
in higher numbers than in healthy volunteers, and (iii) generally different species compared 
with those detected in the non-CF control group (Tunney et al., 2008). Identification of the 
anaerobes isolated revealed 14 different genera with the genus Prevotella, being the most 
frequently isolated before Veillonella, Propionibacterium, and Actinomyces. Prevotella spp. were 
present in 22% to > 80% of the CF patients depending on the study while found in 10% of 
healthy patients (Field et al., 2010; Tunney et al., 2008). Based on cultivation-independent 
methods, Bittar et al. showed the anaerobes to represent 30.2% of the detected species in CF 
sputum specimens (16/53 species) with Prevotella sequences being dominant (48.7%) among 
sequences corresponding to anaerobes (Bittar et al., 2008b). Prevotella melaninogenica is 
usually the most common species identified in these studies. Strict anaerobes are well-
known oral species. However, they were not regarded to be simply contaminants because of 
their diversity and abundance within the CF airways compared to non-CF population 
(Jones, 2011). Among them, Prevotella spp., already known as contributing to the consortia of 
microorganisms involved in several human pathologies attributed to dysbiosis, may 
contribute to CF airway disease (Alauzet et al., 2010; Field et al., 2010). 
What remains also unknown is how the quantitative and/or qualitative modification in the 
composition of the microbiota would affect interactions between organisms. These 
interactions were previously demonstrated in complex microbiota like modulation of P. 
aeruginosa gene expression by host microflora through interspecies communication (Duan et 
al., 2003; Sibley et al., 2008b). It was hypothesized that Prevotella spp. may also modulate P. 
aeruginosa virulence gene expression as well as growth and virulence of the potential CF 
pathogen of the Streptococcus milleri group (Field et al., 2010; Shinzato et al., 1994; Sibley et 
al., 2008a). Unfortunately, Prevotella spp. were not included by Sibley et al. in the 40 
oropharyngeal species tested for both microbe–microbe and polymicrobe–host interactions 
in Drosophila melanogaster infection model (Sibley et al., 2008b). 
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4. Pathogenesis and clinical consequences of colonization by atypical 
bacteria 
Harris et al. previously hypothesized that atypical bacteria may explain inflammation in the 
absence of documented pathogens as well as failure to standard treatment in CF (Harris et 
al., 2007). The clinical significance in CF of bacteria detailed in this chapter remains unclear, 
as it is still the case for more frequently isolated species like A. xylosoxidans (Hauser et al., 
2011).  
Regarding anaerobes, Worlitzsch et al. showed that patients with and without obligate 
anaerobes in sputum specimens did not differ in lung function (Worlitzsch et al., 2009). 
AAB, Agrobacterium, Inquilinus and Ochrobactrum members are considered as opportunistic 
human pathogens, being involved in systemic or severe infections in immunocompromised 
patients or patients with underlying diseases/conditions (Alauzet et al., 2010; Chen et al., 
2008; Cieslak et al., 1996; Kiratisin et al., 2006).  
Case reports documented potential virulence in CF for some of these atypical bacteria. For 
AAB, the first case report in CF documented Acetobacter indonesiensis isolation during 
pneumonia occurring after lung transplant. The bacterium was considered to be the 
primary cause of the infection because of clinical improvement after adapted 
antimicrobial therapy (Bittar et al., 2008a). By contrast, Gluconobacter and Asaia sp. could 
not be incriminated in the evolution of the disease because of a favorable clinical 
evolution without any specific treatment (Alauzet et al., 2010). Case reports also witnessed 
for a potential pathogenic power of Ochrobactrum sp. in CF patients because O. anthropi 
was previously involved: (i) in association with B. diminuta in a case of acute pneumonia 
in a 17-year-old CF patient showing clinical improvement after adapted antimicrobial 
therapy including imipenem and tobramycin (Menuet et al., 2008), (ii) in a case of 
bacteremia in children (Yagüe-Muñoz et al., 2010). Inquilinus isolation was associated 
either with acute pulmonary exacerbation, respiratory decline without signs of acute 
exacerbation or stable respiratory status (Chiron et al., 2005; Schmoldt et al., 2006). To date, 
the patient chronically colonized by Inquilinus sp. in our center has stable respiratory 
status. Inquilinus sp. was also responsible for prosthetic valve endocarditis in a tetralogy 
of Fallot patient (Kiratisin et al., 2006). Additional arguments in favor of pathogenic 
potential of Inquilinus sp. are: (i) specific serum antibody response found in patients with 
Inquilinus sp. (Schmoldt et al., 2006), (ii) mucoid characteristic of Inquilinus sp. that could 
be related to exopolysaccharides, recognised as important virulence factors in lung 
infections, showing novel structures with usual components and similarity with P. 
aeruginosa exopolysaccharides (Herasimenka et al., 2007). Finally, no clinical data 
associated with A. radiobacter isolation in CF are currently available. From our personal 
data, A. radiobacter was mainly a transient colonizer of the CFRT while Ochrobactrum spp. 
displayed more complex relationships with CF host. These species were usually recovered 
at low bacterial load and in mixed cultures from the respiratory secretions sampled in 
patients during scheduled consultations. Their recovery was mainly associated with stable 
respiratory status but in some cases, respiratory decline with or without signs of acute 
exacerbation were noted. In these cases, multiple species were simultaneously isolated 
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Treatment against these species was usually not started except in one case of A. radiobacter 
isolation that was recovered at low bacterial load but in pure culture in a context of respiratory 
decline in a 4-year-old patient. Trimethoprim/sulfamethoxazole treatment for 15 days led to 
eradication of the species from the airways and clinical improvement in this patient. In another 
patient with deteriorated respiratory status, antimicrobial treatment associating ciprofloxacin 
and trimethoprim/sulfamethoxazole was established. According to the antibiograms, this 
treatment was effective against all bacteria cultured from the sputum specimen, i.e. A. 
radiobacter but also D. tsuruhatensis, two enterobacteria and S. aureus, the major species in the 
sample and showed efficacy on the clinical status of the patient.  
Of note, Agrobacterium and/or Ochrobactrum spp. were relatively frequently isolated after 
antimicrobial treatment against P. aeruginosa or S. aureus due to their resistance to 
amoxicillin/clavulanic acid, ceftazidime, tobramycin and/or colistin. Indeed, as previously 
described for other mild opportunistic pathogens of environmental origin like S. maltophilia; 
acetic acid bacteria, Inquilinus and Ochrobactrum spp. displayed a high level of resistance to 
antibacterial compounds (Alauzet et al., 2010; Berg et al., 2005; Bittar et al, 2008a; Thoma et 
al., 2009) (Figure 2). 
Multiresistance-encoding genetic determinant has only been characterized for O. anthropi as 
a chromosomal class C beta-lactamase named OCH-1 while remaining unknown for 
Agrobacterium, AAB, Inquilinus sp. and other Ochrobactrum species (Nadjar et al., 2001). 
Moreover, majority of these species displayed intrinsic resistance to colistin. Agrobacterium 
sp. resisted to several drugs used in CF patients like ceftazidime and tobramycin but 
displayed resistance to less drugs than AAB, Inquilinus and Ochrobactrum. 
 
Fig. 2. Multiresistance pattern to -lactam agents observed for Inquilinus sp. (left) and O. 
intermedium (right) by disk diffusion assay (antibiotic disk position is indicated by 
corresponding drug abbreviation in the middle).  
Abbreviations and concentrations for antibiotics indicated according to disk position are: 
AMX, amoxicillin (25 μg); CF, cephalotin (30 μg); ATM, aztreonam (30 μg); TIC, ticarcillin 
(75 μg); FOX, cefoxitin (30 μg); CTX, cefotaxime (30 μg); CAZ, ceftazidime (30μg);  
TCC, ticarcillin/clavulanic acid (75 μg /10 μg); FEP, cefepime (30 μg); AMC, 
amoxicillin/clavulanic acid (20 μg /10 μg); CPD, cefpodoxime (30 μg); IPM, imipenem (10 
μg); MOX, latamoxef (30 μg); CPO, cefpirome (30 μg); PTZ, piperacillin/tazobactam (75 μg 
/10 μg); PIP, piperacillin (75 μg). 
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There are too few isolates reported in the literature and even fewer CF case reports 
involving these atypical bacteria to drawn conclusion on their clinical relevance in CF. 
Moreover, interactions between these atypical species and other organisms within the 
CFRT microbiota is unknown. Knowledge on the virulence of these atypical bacteria 
required rigorous description and follow-up of cases involving such bacteria. Moreover, 
case control studies will also be needed to determine their clinical implication in CF 
patients as well as risk factors for acquisition. From our experience, it could be 
hypothesized that these species may be selected by antimicrobial therapy against 
pathogens due to their resistance or multidrug resistance. This has been previously 
suggested for S. maltophilia, which has a predilection to infect CF patients with more 
advanced disease and consequently more frequently exposed to broad-spectrum 
antibiotics (Hauser et al., 2011). Similarly, the increased use of nebulized colistin in CF 
patients may select specific colistin-resistant bacteria as previously suggested for B. 
diminuta (Menuet et al., 2008).  
Besides intrinsic resistance, several bacteria present in the CFRT microbiota may acquire 
additional resistance mechanisms. Development of multidrug resistance is a frequent 
finding in CF and is usually mediated by combination of several resistance mechanisms 
(Poole, 2011). Acquired multidrug resistance may also be encoded by extended spectrum 
-lactamases (ESBLs) and carbapenemases, which are increasingly reported in pathogens 
commonly found in CF (P. aeruginosa, S. maltophilia). Enterobacteriaceae can harbor ESBL-
encoding genes localized on mobile genetic elements that may be transferable between 
members of the community. Although such observations remain rare (Cantón et al., 1997; 
2 unpublished isolates in our centre), microbiologists have to be aware of multidrug 
resistant enterobacteria in CF due to pandemic dissemination of some enzymes like CTX-
M ESBLs in the global population (Cantón et al., 2006). In this context, atypical bacteria 
from environmental origin, even transiently colonizing CFRT may constitute a reservoir 
of resistance determinants that can be mobilized into the microbial community, thereby 
contributing to the global increase of the microbiota resistance (Wright, 2010). Moreover, 
antibiotic degrading diffusible enzymes that may be secreted by atypical bacteria are a 
matter of concern. Indeed, antimicrobial treatment against pathogens associated with 
these atypical bacteria may become ineffective due to antibiotic hydrolysis by these 
enzymes. Altogether, bacteria showing multidrug resistance whether this resistance is 
innate or acquired contribute to the increase of the global resistome of the CFRT 
microbiota.  
5. Adaptation of atypical bacteria to the CF airways niche 
5.1 Adaptation to CFRT conditions 
Airways of CF patients represent an ecological niche recognized as a model system for 
studies on bacterial adaptation. Indeed, in this specific niche, the bacteria incoming from the 
outer environment are submitted to complex selective forces from microbiological, 
immunological, physiological and biochemical environment of the CF airways that may 
drive the evolution of the corresponding microorganism (Yang et al., 2011a, 2011b). Several 
microbial species appear to be well adapted to survival within the CF airways (Hauser et al., 
2011). Some species may adapt by forming colony variants, i.e. small-colony variants for S. 
aureus and P. aeruginosa or mucoid colony variants for P. aeruginosa, favoring resistance to 
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antibiotics, evasion to immune system and then long-term persistence in the CF airways. P. 
aeruginosa, the most studied pathogen, may adapt by a wide range of mechanisms that were 
recently reviewed (Hauser et al., 2011).  
For atypical bacteria considered herein, little is known about the mechanisms of adaptation 
to host environment i.e. to CFRT. Extrapolating from P. aeruginosa, mucoid phenotype 
(Inquilinus, Ochrobactrum), antibiotic resistance (Inquilinus, Ochrobactrum, Agrobacterium), 
modifications in lipopolysaccharide (gram-negative genera) or existence of subsets of host-
adapted strains (Ochrobactrum, Agrobacterium) are traits that may favor adaptation to CFRT. 
Although not yet further investigated, we observed diversification in both colonial 
morphology and antibiotype (susceptibility/resistance to fluoroquinolones) after a 6-year 
period of Inquilinus sp. colonization. Moreover, population genetics revealed lineages of 
Agrobacterium and O. anthropi adapted to man but not specifically CF-adapted in contrast to 
P. aeruginosa for which two genotypes were shown as specifically-associated with CF 
(Aujoulat et al., 2010; Romano et al., 2009; van Mansfeld et al., 2010). In addition, some other 
mechanisms of adaptation may be suspected for bacteria covered by this chapter. As far as 
AAB are concerned, it was previously hypothesized that they might specifically colonize the 
CFRT in relation to their ability to grow in acidic conditions. Indeed, this particular 
metabolic trait may confer a selective advantage to these bacteria in the acidified CF airways 
(Alauzet et al., 2010; Poschet et al., 2002).  
5.2 Adaptative evolution in the CFRT 
CFRT is a compartimentalized niche, which is spatially and temporally heterogeneous 
according to the anatomic site and to the period of disease evolution. A variable but 
relatively closed niche could drive diversification and adaptative evolution of the 
microbiota. In addition, mortality agents such as host immunity, antibiotics and lysogenic 
phages could lead to the diversification of a bacterial population that contribute to the 
persistence of the infection, as previously described for P. aeruginosa in the CF lung 
(Brockhurst et al., 2005).  
The ability to switch to hypermutable phenotypes by rapid acquisition of mutations at an 
unusually high rate lead to phenotypic diversification as observed for H. influenzae, S. aureus 
and P. aeruginosa (Hauser et al., 2011). Besides hypermutation, genome plasticity is a 
mechanism for a bacterium to diversify its population and to adapt in various 
environments. Genomic rearrangements have been described in P. aeruginosa to switch from 
a saprophytic to a pathogenic lifestyle. Large chromosomal inversions are associated with 
insertion sequences duplication in P. aeruginosa strains isolated in CF. These events, by 
disrupting genes, have been shown to be involved in phenotypic adaptation of the strains to 
their particular environment (Coyne et al., 2010).  
Genomic macrorestriction followed by PFGE is an efficient tool to follow genomic 
rearrangements, particularly in bacterial species poorly investigated at the genetic level, as 
atypical species isolated from CFRT. Genomic evolution was previously demonstrated in 
serial isolates recovered from the respiratory tract of a non-CF patient chronically colonized 
over a 1.5-year period by O. intermedium (Teyssier et al., 2003). The clone evolved in vivo by a 
deletion of a 150 kb-genomic fragment, which included one copy of ribosomal operon. It 
was suggested that: (i) the new genomic organization gave a selective advantage to the 
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strain in vivo, (ii) the genomic reduction may be an adaptative phenomenon of this free-
living bacterium to the narrow ecological niche represented by the human respiratory tract. 
Indeed, the relation between host-restricted lifestyle and a small genome size is patent in 
bacteria, particularly in alphaproteobacteria (Moreno, 1998). We recently hypothesize that a 
phenomenon of genomic rearrangement might also be observed in Inquilinus sp. strains. 
Investigation was conducted on 21 serial isolates recovered during the 9-year follow-up of a 
CF patient chronically colonized by Inquilinus sp. PFGE analysis revealed the genomic 
stability of the strains while showing the existence of two closely related variants. Genomic 
reduction is suspected in one of the two co-existing variants suggesting that an adaptation 
process to human host is ongoing in these isolates but this should be further investigated 
(Teyssier et al., 2011). This hypothesis was supported by comparison of sequential Inquilinus 
isolates recovered in one German patient revealing identical RAPD profiles but slightly 
different protein patterns. Expression of two antigens disappeared between successively 
isolated strains and was considered as suggestive of an adaptation of the Inquilinus clone 
during the course of infection (Schmoldt et al., 2006). As observed by PFGE, the two variants 
co-existed in the respiratory tract.  
6. Hypothesis: CFRT is a hotspot for emergence of human pathogens  
The emergence of human pathogens from environment involves a dramatic jump in the 
lifestyle of bacteria. CFRT and atypical bacteria provide examples for different types of 
lifestyle switches. Bacteria like Ochrobactrum spp. have a very versatile behavior with no 
obvious pathogenicity except in man but with close association with diverse organisms, 
association that can be as close as symbiosis (Teyssier et al., 2004). In the respiratory tract, 
O. intermedium can evolve by genomic reduction until displaying a genome structure 
similar to Brucella, an intracellular strict pathogen phylogenetically related to 
Ochrobactrum spp. (Teyssier et al., 2003). In some cases, pathogenic microorganisms are 
capable to cause disease in a variety of organisms that may belong to different biological 
kingdoms of life. Such cross-kingdom pathogenesis could be illustrated by A. 
radiobacter/tumefaciens that causes both plant and human diseases. The virulence factors 
involved in phytopathogenicity are not found in clinical strains (unpublished data). 
However, multi-locus phylogeny showed that the clinical strains belonged to an epidemic 
clone among the Agrobacterium spp. population. This epidemic clone so-called genovar A7 
could correspond to a new species in the genus and presented some phenotypic characters 
such as growth at 40 °C, which is a basic trait for human pathogenicity (Aujoulat et al., 
2011). The bacterial lifestyle needs basic requirements such as temperature, water, 
nutrients and pH optima. In human-associated Agrobacterium, growth at high temperature 
is an emergent character. In other cases, basic requirements may be similar in both 
pathogenic and harmless members of neighbor clades, hence considered to be pre-existing 
adaptations. Different members of the Acetobacteraceae could infect human suggesting that 
they shared common traits, such as ability to grow at acidic pH, that permits their 
opportunistic growth, particularly in CFRT.  
One primary condition for colonization and pathogenicity is the probability to meet the 
bacteria that implies living in close proximity. AAB could be considered as “domestic” for 
human since they were used for a long time in food processing. This situation differed from 
that observed for Inquilinus, which is the sole genus to include human-adapted bacteria in 
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Rhodospirillaceae. I. limosus emerged from the family Rhodospirillaceae, a group found in soil 
and plant but totally unrelated to human beings. Association with coral, sponge and 
cuttlefish is also described, particularly in the neighborhood of the genus Inquilinus. It is 
noteworthy that, when associated with animals, Rhodospirillaceae are found in mucous or 
gelatinous environment, such as the egg capsule in sepia. 16S rDNA sequences of I. 
ginsengisoli described from the soil of ginseng fields differed slightly from that of I. limosus 
type strain (Jung et al., 2011). 16S rDNA-based phylogeny showed a short robust branch 
(bootstrap value at 85) that groups all the clinical isolates and only one environmental 
isolate from roots of a perennial grass of Thar Desert in India (Figure 3). In a rooted tree, this 
branch appeared as supporting the most recently emerging species in the Inquilinus genus 
(data not shown). Finally, no relationship with human or other mammals was found for 
bacteria in the phylogenetic neighborhood of Inquilinus. Therefore, we could hypothetize 
that the association of I. limosus with CFRT resulted from a recent emergence by a speciation 
process of a human-adapted species from a group that experimented life in mucous 
environment. 
 
Fig. 3. Maximum-likelihood phylogenetic tree based on partial 16S rRNA gene sequences 
showing relationship among members of the genus Inquilinus and between Inquilinus spp. 
and selected close relatives from the family Rhodospirillaceae. Genbank accession numbers, 
isolation source and host follow sequence names. Numbers at nodes indicate percentage 
bootstrap support, based on analysis of 100 replicates. They are indicated for major nodes 
when >70. Bar, 0.02 substitutions per site. 
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We showed that the manner that CFRT niche drive the speciation and the adaptative evolution 
of bacteria is not univocal. However, the CFRT formed an abnormal human niche with basic 
conditions that allow the installation of environmental bacteria generally unrelated to human 
beings. Bacteria associated with CFRT, occupy two types of anatomical regions: i) the lower 
regions of the respiratory tract that are normally free of bacteria ii) the upper regions of the 
respiratory tract that are normally colonized by a resident microbiota. In CFRT, both dysbiosis 
and colonization by atypical environmental bacteria lead to a modified ecosystem where 
bacterial interactions may be unbalanced. The CFRT could be considered as an ecosystem with 
an emerging community where many bacteria belonging to different phyla interact and 
exchange genes at an increased rate. Lateral gene exchange is recognized as main innovation 
source for bacteria. They can acquire new genomic repertoires from which clonal specialists 
could emerge. Hotspots of interaction and exchange such as amoeba and rhizosphere have 
been previously described (Berg et al., 2005; Saisongkorh et al., 2010). The hypothesis that CFRT 
could play this role is reinforced by the number of atypical bacteria observed in this niche and 
by the probable emergence of specific sub-populations or species. Thus, emergence of 
opportunistic human pathogens from environmental origin may be first recognized from the 
CF airways model, a niche for bacterial adaptation and emergence (Yang et al., 2011b). 
7. Conclusion 
Atypical bacteria are increasingly recognized in CF. These bacteria may be considered as 
emerging from both biological and methodological points of view in CF. Recognition of 
these atypical bacteria should be encouraged in the perspective of a more complete 
description of their prevalence, relative importance of encountered species, antimicrobial 
susceptibility patterns and clinical relevance.  
Despite some candidate pathogens were proposed, the role of these atypical bacteria in the 
disease evolution is unknown. More than considering individual pathogenic species, the 
diversity of the microbiota is more and more considered as an important marker in the 
evolution of the disease. Klepac-Ceraj et al. recently suggested that community composition 
might be a better predictor of disease progression than the presence of P. aeruginosa alone 
(Klepac-Ceraj et al., 2010) and van der Gast et al. showed that taxa richness decreased with a 
reduction in lung function (van der Gast et al., 2011). From this point of view, each taxon 
contributing to increase the global diversity of the microbiota appeared important whatever 
its identification.  
Finally, whether these species may interact with other members of the CFRT microbiota and 
with more common pathogens to influence the onset and/or the evolution of 
colonization/infection by typical pathogens like P. aeruginosa are great questions for future 
advances in CF-associated infectious diseases.  
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